Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Hypothyroidism 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Milk × Clear all
NCT00204477 2024-01-23

Soy Protein and Breast Cancer Risk Reduction

The University of Texas Medical Branch, Galveston

Phase 2 Completed
321 enrolled 14 charts
Breast

Breast Neoplasms

NCT01707056 2021-02-17

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Medstar Health Research Institute

Phase NA Withdrawn
Head & Neck

Hypothyroidism, Thyroid Neoplasms

NCT00597532 2016-04-13

Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study

Memorial Sloan Kettering Cancer Center

Phase NA Completed
140 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡